VNRX•benzinga•
VolitionRX Announces Automated Nu.Q Cancer Test Detects 21 Cancer Types at High Specificity with Low False Positive Rate Among Healthy Patients; Potential for Use as Standalone Pan-Cancer Test or in Conjunction with Other Biopsy Technologies
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 21, 2025 by benzinga